@msn81 OK it sounds like MM thinks they won't need to do anymore...

@msn81 OK it sounds like MM thinks they won't need to do anymore phase 2 trials. This doesn't of course mean they won't as this will depend on the outcome of the talks with potential large pharma partners. If they want more phase 2 data before committing the funds to a phase 3 trial they will have to do more phase 2 trials.

I take it from your response that nobody specifically asked if the cell-associated virus data will be released next week?

I don't really have much more to add until the conference data is released.